The present study also revealed that EGFR mutations in advanced lung carcinoma were more frequently associated with intra-thoracic metastases to the lung and pleura, and the absence of lymphadenopathy and extranodal invasion, compared to the KRAS and ALK mutations. This evidence concerns the gene ALK and lung carcinoma.